标题
The treatment of depression — searching for new ideas
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-10-07
DOI
10.3389/fphar.2022.988648
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
- (2022) Mario Gennaro Mazza et al. CNS DRUGS
- Investigational Drugs for the Treatment of Depression (Part 1): Monoaminergic, Orexinergic, GABA-Ergic, and Anti-Inflammatory Agents
- (2022) Octavian Vasiliu Frontiers in Pharmacology
- Investigational Drugs for the Treatment of Depression (Part 2): Glutamatergic, Cholinergic, Sestrin Modulators, and Other Agents
- (2022) Octavian Vasiliu Frontiers in Pharmacology
- Multiple signaling pathways are essential for synapse formation induced by synaptic adhesion molecules
- (2021) Xian Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increases in depression and anxiety symptoms in adolescents and young adults during the COVID-19 pandemic
- (2021) Mariah T. Hawes et al. PSYCHOLOGICAL MEDICINE
- Synthesis of Novel Pyrido[1,2-c]pyrimidine Derivatives with 6-Fluoro-3-(4-piperidynyl)-1,2-benzisoxazole Moiety as Potential SSRI and 5-HT1A Receptor Ligands
- (2021) Marek Król et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IGF-1 as selected growth factor multi-response to antidepressant-like substances activity in C57BL/6J mouse testis model
- (2021) Anna Tabecka-Lonczynska et al. ACTA HISTOCHEMICA
- Depression
- (2021) Robert M. McCarron et al. ANNALS OF INTERNAL MEDICINE
- Time use and mental health in UK adults during an 11-week COVID-19 lockdown: a panel analysis
- (2021) Feifei Bu et al. BRITISH JOURNAL OF PSYCHIATRY
- Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders
- (2021) Felicia Ceban et al. CNS DRUGS
- Investigating the potential mechanisms of depression induced-by COVID-19 infection in patients
- (2021) Ali Mohammadkhanizadeh et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium
- (2021) Gustavo H. Vázquez et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Combination of Cognitive-Behavioural Therapy with Virtual Reality for the Treatment of Postnatal Depression in a Brief Intervention Context: A Single-Case Study Trial
- (2021) George Stamou et al. Journal of Healthcare Engineering
- Antidepressant Drugs Effects on Blood Pressure
- (2021) Anna Calvi et al. Frontiers in Cardiovascular Medicine
- Trade‐offs between male fertility reduction and selected growth factors or the klotho response in a lipopolysaccharide-dependent mouse model
- (2021) Przemyslaw Solek et al. Toxicological Research
- Deciphering the mechanisms of regulation of an excitatory synapse via cyclooxygenase-2. A review
- (2021) Katarzyna Stachowicz BIOCHEMICAL PHARMACOLOGY
- Evidence for the interaction of COX-2 with mGluR5 in the regulation of EAAT1 and EAAT3 protein levels in the mouse hippocampus. The influence of oxidative stress mechanisms
- (2021) Katarzyna Stachowicz et al. BRAIN RESEARCH
- Efficacy, Safety, and Tolerability of Ansofaxine (LY03005) Extended-Release Tablet for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Clinical Trial
- (2021) Weifeng Mi et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Mental depression: Relation to different disease status, newer treatments and its association with COVID-19 pandemic (Review)
- (2021) Mohamed Abdel-Bakky et al. Molecular Medicine Reports
- The Effects and Mechanisms of Exercise on the Treatment of Depression
- (2021) Yumeng Xie et al. Frontiers in Psychiatry
- Functional interactions of ion channels with the actin cytoskeleton: does coupling to dynamic actin regulate NMDA receptors?
- (2020) Juliana E. Shaw et al. JOURNAL OF PHYSIOLOGY-LONDON
- Mental and somatic comorbidity of depression: a comprehensive cross-sectional analysis of 202 diagnosis groups using German nationwide ambulatory claims data
- (2020) Annika Steffen et al. BMC Psychiatry
- Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents
- (2020) Molly C. Kalmoe et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Seasonal changes in NRF2 antioxidant pathway regulates winter depression-like behavior
- (2020) Tomoya Nakayama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Postpartum Depression
- (2020) Emily B. Kroska et al. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
- Combination of Electroconvulsive Therapy Alternating With Intravenous Esketamine Can Lead to Rapid Remission of Treatment Resistant Depression
- (2020) Erhan Kavakbasi et al. JOURNAL OF ECT
- Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder
- (2020) Jenny Guidi et al. JAMA Psychiatry
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
- (2019) Antonio Cuadrado et al. NATURE REVIEWS DRUG DISCOVERY
- Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development
- (2019) Natalia Robledinos-Antón et al. Oxidative Medicine and Cellular Longevity
- COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders
- (2019) Norbert Müller Frontiers in Psychiatry
- Brexanolone (Zulresso): Finally, an FDA-Approved Treatment for Postpartum Depression
- (2019) Jason G Powell et al. ANNALS OF PHARMACOTHERAPY
- The Microbiota-Gut-Brain Axis
- (2019) John F. Cryan et al. PHYSIOLOGICAL REVIEWS
- Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
- (2019) Rickinder Sethi et al. Frontiers in Psychiatry
- Synthesis of new 5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT1A receptor ligands
- (2019) Grzegorz Ślifirski et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of new multi-target 3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with potential antidepressant effect
- (2019) Martyna Z. Wróbel et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Looking for bipolarity in antidepressant discontinuation manic states: Update and diagnostic considerations of the phenomenon
- (2018) Sandra Abou Kassm et al. JOURNAL OF AFFECTIVE DISORDERS
- Adverse effects of interactions between antidepressants and medications used in treatment of cardiovascular disorders.
- (2018) Jarosław Woroń et al. Psychiatria Polska
- Mental and Behavioural Disorders in the ICD-11: Concepts, Methodologies, and Current Status
- (2017) Wolfgang Gaebel et al. Psychiatria Polska
- The potential impact of gut on your health: Current status and future challenges
- (2016) ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY
- Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression
- (2016) E Bouvier et al. MOLECULAR PSYCHIATRY
- Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression
- (2015) M Udina et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Augmentation Treatments with Second-generation Antipsychotics to Antidepressants in Treatment-resistant Depression
- (2013) Masaki Kato et al. CNS DRUGS
- MAJOR DEPRESSIVE DISORDER IN DSM-5: IMPLICATIONS FOR CLINICAL PRACTICE AND RESEARCH OF CHANGES FROM DSM-IV
- (2013) Rudolf Uher et al. DEPRESSION AND ANXIETY
- Distinct roles of synaptic and extrasynaptic GABAAreceptors in striatal inhibition dynamics
- (2013) Ruixi Luo et al. Frontiers in Neural Circuits
- The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
- (2013) Emilia Kansanen et al. Redox Biology
- A breach in the scaffold: The possible role of cytoskeleton dysfunction in the pathogenesis of major depression
- (2012) Ginger Tsz-Hin Wong et al. AGEING RESEARCH REVIEWS
- The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses
- (2012) Masaaki Iwata et al. BRAIN BEHAVIOR AND IMMUNITY
- Genetics and Personalized Medicine in Antidepressant Treatment
- (2012) Katarina Gvozdic et al. CURRENT PHARMACEUTICAL DESIGN
- Extrasynaptic GABAA Receptors: Their Function in the CNS and Implications for Disease
- (2012) Stephen G. Brickley et al. NEURON
- The size and burden of mental disorders and other disorders of the brain in Europe 2010
- (2011) H.U. Wittchen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity. part 3
- (2010) Franciszek Herold et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Kinetic and Thermodynamic Assessment of Binding of Serotonin Transporter Inhibitors
- (2008) R. S. Martin et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Antidepressants Targeting the Serotonin Reuptake Transporter Act via a Competitive Mechanism
- (2008) S. Apparsundaram et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Efficacy of light therapy in nonseasonal depression: A systematic review
- (2007) Christian Even et al. JOURNAL OF AFFECTIVE DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search